Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

Abstract Background Direct-acting antivirals (DAAs) have revolutionized chronic hepatitis C (HCV) treatment, but real-world effectiveness among vulnerable populations, including uninsured patients, is lacking. This study was conducted to characterize the effectiveness of DAAs in a socioeconomically...

Full description

Bibliographic Details
Main Authors: Christina Yek, Carolina de la Flor, John Marshall, Cindy Zoellner, Grace Thompson, Lisa Quirk, Christian Mayorga, Barbara J. Turner, Amit G. Singal, Mamta K. Jain
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Medicine
Subjects:
Chronic hepatitis C
Direct-acting antiviral therapy
Real-world cohort
Safety-net hospital
Indigent population
Online Access:http://link.springer.com/article/10.1186/s12916-017-0969-3

Internet

http://link.springer.com/article/10.1186/s12916-017-0969-3

Similar Items